LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM
Article in Molecular Cancer (January 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Aberrant RNA Splicing and Therapeutic Reprogramming in Cancer
Book chapter (October 2023)
LINC01852 inhibits tumorigenesis and chemoresistance in colorectal cancer by regulating SRSF5-mediated PKM alternative splicing
Preprint in Research Square (August 2023)